FDA approves Roche’s Susvimo for neovascular or “wet” age-related macular degeneration (nAMD) Read more
Biocon Biologics and Viatris’s Semglee preferred on Express Scripts’ largest formulary in US Read more
Pfizer-BioNTech phase-III trial data shows high efficacy of a booster dose of their COVID-19 vaccine Read more